Priority Date: 02.02.12 (US 201261593864P)

ALK1 ANTAGONISTS AND THEIR USES IN TREATING RENAL CELL CARCINOMA

  • Application ID: EP13744185
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

no operation time available
696.27
2 offices
active in Legal Services

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Schlich LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 02.02.2012 - Priority Date (US 201261593864P)
  • 08.08.2013 - Publication A1 (WO2013116781)
  • 10.12.2014 - Publication A1 (EP2809335)

IPC Classification